Immunotherapy and Immune Prevention in Lynch Syndrome - Session 3

Explore a comprehensive session of lectures focusing on immunotherapy and immune prevention strategies for Lynch syndrome, featuring expert presentations from leading cancer research institutions. Learn about exercise-induced mucosal response from Dr. Eduardo Vilar-Sanchez of MD Anderson Cancer Center, discover the latest developments in immune checkpoint inhibitor therapy for early-stage Lynch syndrome cancers presented by Dr. Michael Foote from Memorial Sloan Kettering Cancer Center, and understand immunoprevention approaches and upcoming vaccine trials through another insightful presentation by Dr. Vilar-Sanchez. Gain valuable insights through the concluding panel Q&A session that addresses key questions about these cutting-edge treatment and prevention approaches in the field of cancer research.